IMNM

15.6905.54%
JP

James Patrick Boylan

Independent Director

Mr. James Patrick Boylan, also known as Jim, M.B.A., is Lead Independent Director of Zenas BioPharma, Inc. Mr. Boylan was Independent Director of Zenas BioPharma, Inc. from November 2022. He is Independent Director of Immunome, Inc. from October 2023. He is Independent Director of Compass Therapeutics, Inc. from November 2022. He is Director of Zenas BioPharma Limited from 2022. He is Director of Graviton Bioscience Corporation. He is CEO & Director of Enavate Sciences. He joined the Enavate Sciences in May 2022. He was Chief Executive Officer of Enavate Sciences. He is Senior Advisor of Patient Square Capital, LP. He was Independent Director of Camp4 Therapeutics Corporation from June 2022 to September 9, 2025. He was employed at Camp4 Therapeutics Corporation until September 9, 2025. He was President & Global Co-Head of Investment Banking of Leerink Partners LLC until 2021. He was President & Head of Investment Banking of Leerink Partners LLC. He was employed at Leerink Partners LLC until 2021. Mr. Boylan has few decades of experience as an accomplished health care executive, entrepreneur and innovator. Mr. Boylan architected and led the transformation of Leerink Swann. Across his several years at SVB Leerink and prior several years as a Managing Director at Merrill Lynch, Mr. Boylan worked with several of life sciences and biotechnology companies to develop strategies and complete transactions. Mr. Boylan currently serves on the Board of Directors of Camp4 Therapeutics, Compass Therapeutics, Zenas BioPharma and Immunome, Inc. He has B.S. in Finance from Lehigh University in 1989 and M.B.A. in Finance from Columbia University International in 1994.

Positions